Poolbeg Pharma PLC
POLB.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | £0 | £0 | £0 | £0 |
| Gross Profit | -£0 | -£0 | -£0 | -£0 |
| % Margin | – | – | – | – |
| R&D Expenses | £1 | £1 | £0 | £1 |
| G&A Expenses | £0 | £3 | £0 | £0 |
| SG&A Expenses | £2 | £3 | £0 | £2 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £2 |
| Other Operating Expenses | £0 | £0 | £3 | £0 |
| Operating Expenses | £3 | £4 | £3 | £3 |
| Operating Income | -£3 | -£4 | -£3 | -£3 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | £0 | £0 | £1 | £0 |
| Pre-Tax Income | -£2 | -£4 | -£2 | -£3 |
| Tax Expense | -£0 | £0 | -£0 | -£1 |
| Net Income | -£2 | -£4 | -£2 | -£2 |
| % Margin | – | – | – | – |
| EPS | -0.004 | -0.007 | -4.52 | -4.3 |
| % Growth | 39.4% | 99.8% | -5.1% | – |
| EPS Diluted | -0.004 | -0.007 | -4.52 | -4.28 |
| Weighted Avg Shares Out | 507 | 497 | 1 | 0 |
| Weighted Avg Shares Out Dil | 507 | 500 | 1 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £0 | £0 | £0 |
| EBITDA | -£2 | -£3 | -£2 | -£3 |
| % Margin | – | – | – | – |